News Daily News TAVI Patients Seem to Pay No Penalty for Obstructive CAD Yael L. Maxwell December 09, 2025
News Conference News EACTS 2025 SAVR Bests TAVI for 5-Year Survival in Combined RCT, Observational Data Yael L. Maxwell October 10, 2025
News Daily News Balloon, Self-Expanding TAVI Devices Provide Similar Results in Bicuspid Valves Caitlin E. Cox August 26, 2025
News Conference News EuroPCR 2025 Stroke Risk Higher With TAVI vs Surgery at 5 Years: UK TAVI Michael O'Riordan May 23, 2025
News Conference News EuroPCR 2025 Lower MACE Risk With FFR- vs Angio-Guided PCI in AS Patients: FAITAVI L.A. McKeown May 22, 2025
News Conference News EuroPCR 2025 Higher Mortality With TAVI Over Surgery in Bicuspid Aortic Stenosis Michael O'Riordan May 22, 2025
News Daily News TAVI and Complex/High-Risk PCI Safer if Staged, Registry Confirms Caitlin E. Cox April 28, 2025
News Conference News ACC 2025 Evolut Low Risk Trial: TAVI Holds Up to Surgery at 5 Years L.A. McKeown March 30, 2025
News Features What’s in a Name: Is It Time to Choose Between TAVI and TAVR? Yael L. Maxwell March 27, 2025
News Conference News STS 2025 STS Experts Tackle Need For Women-Only Trials in Surgery Yael L. Maxwell January 29, 2025
News Daily News Some Guidance for Managing Patients With AS and CAD: Review Yael L. Maxwell December 24, 2024
News Conference News AHA 2024 ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery Yael L. Maxwell November 17, 2024
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for September 2024 Shelley Wood October 01, 2024
News Conference News ESC 2024 MitraClip vs Surgery for Severe FMR? MATTERHORN Claims Noninferiority Shelley Wood September 01, 2024
News Conference News ESC 2024 NOTION-3: PCI Before TAVI Lowers MACE Risks in Patients With Significant CAD Michael O'Riordan September 01, 2024
News Daily News Evolut TAVI Shows Promise in Low-risk Bicuspid Patients at 3 Years Yael L. Maxwell July 22, 2024
Presentation NY Valves 2024 A Randomized Comparison of TAVR and SAVR in Low-Risk Patients Aged 70 Years or Younger: Results From the NOTION-2 Trial Presenter: Ole De Backer June 05, 2024
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for May 2024 Shelley Wood May 31, 2024
News Conference News EuroPCR 2024 Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids Michael O'Riordan May 15, 2024
Presentation EuroPCR 2024 First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2 Presenter: Ole De Backer May 15, 2024